Apart from t (9;22) (q34;q11)/BCR-ABL and t (4;11) (q21;q23)/MLL-AF4, an elevated white blood cell count, age over 40 and non-responders/slow responders to chemotherapy are commonly regarded as high risk criteria in ALL [11]. This evidence concerns the gene ABL1 and acute lymphoblastic leukemia.